Former Sky News host Dermot Murnaghan diagnosed with stage four prostate cancer
The broadcaster, 67, who spent more than 15 years at the news channel before his departure in 2023, said he is 'responding positively' to treatment in a post to X on Monday.
'Some personal news… I've been diagnosed with Stage IV advanced prostate cancer', he said.
'I'm fortunate to have a simply outstanding medical team looking after me, who I can't thank enough – they are administering the best possible care with expertise, compassion and sensitivity.
Some personal news……I've been diagnosed with Stage IV advanced prostate cancer I'm fortunate to have a simply outstanding medical team looking after me, who I can't thank enough – they are administering the best possible care with expertise, compassion and sensitivity.
— Dermot Murnaghan (@DermotMurnaghan) June 23, 2025
'I'm responding positively to their excellent treatment, and feeling well.'
Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, such as the back passage or bladder, nearby lymph nodes and other parts of the body outside the pelvis, such as the bones, lungs or liver, according to the Cancer Research UK website.
'I'm blessed to be fortified by the monumental love and support of my wife, family and close friends', Murnaghan said.
'Needless to say my message to all men over 50, in high risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS.'
He also said that he is aiming to take part in Sir Chris Hoy's fundraising charity bike ride in September which will raise awareness and funds for cancer charities across the UK.
The Olympian announced he had a terminal diagnosis for prostate cancer in October 2024.
The Tour de 4 ride, which will begin and end at the Sir Chris Hoy velodrome in Glasgow on September 7, aims to change the perception of people living with stage four cancer.
NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier.
About one in eight men will get prostate cancer in their lifetime, according to the charity Prostate Cancer UK, and the disease often has no symptoms in its earlier stages.
Murnaghan presents true crime documentary series Killer Britain and the podcast Legends Of News.
Before joining Sky News, Murnaghan presented ITV's News At Ten and the BBC Ten O'Clock News – now known as BBC News At Ten – as well as Channel 4 News.
Murnaghan also hosted the BBC's quiz programme Eggheads and presented Sky News At Ten and talk show Murnaghan before his last role at the channel as a newsreader on Sky News Tonight.
During his time, he covered big events such as the announcement of the death of Queen Elizabeth II, the 2019 general election, the funeral of Prince Philip and the 2020 US presidential election.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Herald Scotland
27 minutes ago
- The Herald Scotland
Sponge test ‘could benefit thousands of people' with Barrett's oesophagus
This condition occurs when stomach acid damages the lining of the oesophagus (the food pipe). Some cells may grow abnormally and develop into oesophageal cancer. At the moment, the NHS offers regular monitoring of the condition every two to five years with an endoscopy, which involves passing a tube with a camera into the oesophagus. However, a new, less invasive test called a capsule sponge test could be used instead for some patients, researchers believe. The test is already being used in some NHS hospitals to diagnose the condition. The new Lancet study, funded by Cancer Research UK, NHS England Cancer Alliance and Innovate UK, was carried out at 13 hospitals in the UK. Some 910 people took part and were given the capsule test. This involves a patient swallowing a capsule attached to a string. The capsule dissolves in their stomach and leaves a small sponge. The sponge is then pulled out via the string by NHS staff after a few minutes, during which time it collects cells from the oesophageal lining. In the study, around 15% of patients were found to be at high risk of developing cancer, while more than half (54%) were classed as low risk. The authors concluded that the capsule sponge could then be used to monitor patients with low-risk Barrett's oesophagus instead of regular endoscopies, and the test could be administered by nurses in GP practices. The study was from researchers at the University of Cambridge, Addenbrooke's Hospital and Queen Mary University of London. Professor Peter Sasieni from the Cancer Research UK's cancer prevention trials unit at Queen Mary University of London said: 'Our findings suggest that the capsule sponge could help stratify patients with Barrett's oesophagus by risk and that half of them will fall into the low-risk group. 'Given that the risk of these individuals progressing to dysplasia (abnormal cells) and then to oesophageal cancer is so low, it should be safe to replace their usual endoscopy with the capsule sponge.' Professor Rebecca Fitzgerald, from Cambridge, added: 'We are very excited by these results, which could lead to a test that is much more accessible and less operator dependent to improve standards for monitoring for patients with Barrett's across the NHS and beyond.' Chief executive of Cancer Research UK, Michelle Mitchell, said: 'Survival rates for oesophageal cancer have remained unacceptably low for decades, with fewer than 20% of patients surviving for five or more years after diagnosis. 'Early detection is vital if we are to change this grim statistic. 'The Cancer Research UK–backed capsule sponge represents one of the most promising breakthroughs in early detection we have seen to date. 'These new findings bring us closer to transforming the way we diagnose and ultimately treat this disease. 'If adopted widely, this innovative approach could spare significant numbers of people from discomfort and invasive endoscopies. By bringing this more accessible alternative into community care, we have the potential to save more lives.'
Daily Mail
30 minutes ago
- Daily Mail
KATE WILLS: I'm pregnant and fearful. Every woman I know has a horror story about giving birth on the NHS
When I found out I was pregnant in January, after two miscarriages and a round of IVF, I was overwhelmed with delight . . . quickly followed by a state of anxiety, which has only increased with the size of my bump. Why? Because in three months' time I'll be having my baby at Homerton Hospital in east London, where in a recent online petition, the postnatal ward is described as 'an uncomfortable and distressing environment for new mothers'. Yesterday the Health Secretary, Wes Streeting, launched a 'rapid national investigation' into 'systemic' failures in NHS maternity services in England, saying 'maternity units are failing, hospitals are failing, trusts are failing, regulators are failing'. But do we really need yet another inquiry? No, what women require now is action. The bad treatment women have experienced at my local hospital is sadly not an anomaly. In 2022, the Ockenden review found that urgent and sweeping changes are needed in all English hospitals to prevent avoidable baby deaths, stillbirths and neonatal brain damage. The damning report had been looking into one of the biggest scandals in the history of the NHS, where grim failures at Shrewsbury and Telford Hospital NHS Trusts between 2000 and 2019 led to 1,862 serious incidents including hundreds of baby deaths and an unusually high number of maternal deaths. Yet it seems very little has changed. In February, Nottingham University Hospitals NHS Trust was fined £1.6 million after admitting it failed to provide safe care and treatment to three babies who died within months of one another. But it's not just the odd hospital. Last year a Care Quality Commission (CQC) report, based on inspections of 131 maternity units, found that cases of women receiving poor care and being harmed in childbirth are in danger of becoming 'normalised'. Every woman I know has a traumatic horror story about giving birth in an NHS hospital. One friend had such a distressing labour – 40 hours, very little food, left in a pool of her own blood – she's decided she can't go through it again, even though she wanted a second child. Preparing to give birth should be a time of excitement and joy, not fear. When I had my daughter Blake in 2020, I – thankfully – had a relatively straightforward birth, though it was still the most physically traumatic event of my life. At one stage, I was covered in blood and vomit, lying in a brightly lit room filled with medics, as one of them pulled me apart with brute force. I still have flashbacks and I'm not surprised that roughly nine per cent of women experience postpartum PTSD. This time around, the cracks at my hospital have shown from the outset. My first 'booking in' appointment with a midwife was so bad, I made a complaint. I was given incorrect advice about the medications I was taking for my IVF. I was assured I'd never see him again, but ended up back in front of him last week. I've often waited more than an hour for my appointments. Some of the staff have been great, but they seem stressed and overworked to the point of exhaustion. Midwifery used to be a respected profession and women would often see just one midwife for the duration of their pregnancy and birth. Now a midwife's salary starts at £28,407, and they're leaving in droves. The Royal College of Midwives says there's an estimated shortfall of 2,500 full-time equivalent midwives in England alone. And I need all the help an expert midwife can give me. I'm 40 and it's an IVF pregnancy. I've been advised to have an induction but the thought has left me terrified – it can lead to more medical interventions and a longer stay in a maternity ward friends have described as 'being like one in the developing world'. I've looked at choosing another London hospital to give birth in, one which doesn't have such terrible reviews, but as my labour with my daughter was relatively short, I worry I wouldn't get there in time. So I'm trapped in an NHS system that I know may well put my – and my baby's – lives at risk. Wes Streeting commissioning yet another limp investigation feels like a waste of time. We know from the Ockenden review what would improve services: more midwives with better training, better pay for maternity staff, more support. Why not use the money being spent on this inquiry to fund maternity units? The Health Minister might say this investigation will be 'rapid', but it won't be rapid enough for me, or the millions of other women due to give birth this year in failing maternity units nationwide. All we can do is hope and pray for the best. These days it feels like the real miracle of childbirth is not just your bundle of joy, but getting through the experience unscathed.
Powys County Times
32 minutes ago
- Powys County Times
Sponge test ‘could benefit thousands of people' with Barrett's oesophagus
Thousands of people being monitored for food pipe cancer could be spared invasive tests thanks to a 'sponge on a string' check, research suggests. A new study published in the Lancet medical journal found invasive endoscopies could be replaced for over half of patients with Barrett's oesophagus. This condition occurs when stomach acid damages the lining of the oesophagus (the food pipe). Some cells may grow abnormally and develop into oesophageal cancer. At the moment, the NHS offers regular monitoring of the condition every two to five years with an endoscopy, which involves passing a tube with a camera into the oesophagus. However, a new, less invasive test called a capsule sponge test could be used instead for some patients, researchers believe. The test is already being used in some NHS hospitals to diagnose the condition. The new Lancet study, funded by Cancer Research UK, NHS England Cancer Alliance and Innovate UK, was carried out at 13 hospitals in the UK. Some 910 people took part and were given the capsule test. This involves a patient swallowing a capsule attached to a string. The capsule dissolves in their stomach and leaves a small sponge. The sponge is then pulled out via the string by NHS staff after a few minutes, during which time it collects cells from the oesophageal lining. In the study, around 15% of patients were found to be at high risk of developing cancer, while more than half (54%) were classed as low risk. The authors concluded that the capsule sponge could then be used to monitor patients with low-risk Barrett's oesophagus instead of regular endoscopies, and the test could be administered by nurses in GP practices. The study was from researchers at the University of Cambridge, Addenbrooke's Hospital and Queen Mary University of London. Professor Peter Sasieni from the Cancer Research UK's cancer prevention trials unit at Queen Mary University of London said: 'Our findings suggest that the capsule sponge could help stratify patients with Barrett's oesophagus by risk and that half of them will fall into the low-risk group. 'Given that the risk of these individuals progressing to dysplasia (abnormal cells) and then to oesophageal cancer is so low, it should be safe to replace their usual endoscopy with the capsule sponge.' Professor Rebecca Fitzgerald, from Cambridge, added: 'We are very excited by these results, which could lead to a test that is much more accessible and less operator dependent to improve standards for monitoring for patients with Barrett's across the NHS and beyond.' Chief executive of Cancer Research UK, Michelle Mitchell, said: 'Survival rates for oesophageal cancer have remained unacceptably low for decades, with fewer than 20% of patients surviving for five or more years after diagnosis. 'Early detection is vital if we are to change this grim statistic. 'The Cancer Research UK–backed capsule sponge represents one of the most promising breakthroughs in early detection we have seen to date. 'These new findings bring us closer to transforming the way we diagnose and ultimately treat this disease. 'If adopted widely, this innovative approach could spare significant numbers of people from discomfort and invasive endoscopies. By bringing this more accessible alternative into community care, we have the potential to save more lives.'
